Latest Industry Insights
Industry Insight
Bridging the Gap Between Stem Cell Therapy Research and Clinical Trials
Dr. Bo Wiinberg, chief business development officer at the Novo Nordisk Foundation Cellerator, discusses the current obstacles halting advances in stem cell-based cell therapies and what can be done to overcome them.
Industry Insight
Simplifying Cell Visualization in Complex Model Systems
bit.bio’s GFP ioMicroglia enables real-time tracking of microglia in complex co-cultures and in vivo, streamlining neurodegeneration research and drug discovery.
Industry Insight
Advancing Flow Cytometry With High-Throughput Analysis and Automation
Technology Networks spoke with Dr. Richard Cuthbert, cell biology product manager at Bio-Rad, to learn more about Bio-Rad's new ZE5 Cell Analyzer, the challenges within the field and recent technological advancements in flow cytometry.
Industry Insight
Breaking New Ground in Single-Cell Lipidomics
Gilberto Barcellos and Dr. Melanie Bailey discuss the growing interest in single-cell lipidomics, the key challenges researchers face and how the SS2000 is helping to overcome these hurdles.
Industry Insight
Advancing Antibody Innovation Through Discovery, Customization and Sustainability
In this interview, Technology Networks spoke with Dr. Sophie Mayle, Dr. Paul Royle and Dr. John Cardone from Bio-Rad's custom antibody services team, to learn more about the developments and future directions within antibody innovation.
Industry Insight
Why Good Science Is Key to Good Technology
In this opinion piece, Philipp Koellinger explores the changes required to level the playing field and accelerate both scientific and technological progress.
Industry Insight
The Role of Cytokines and Growth Factors in Advancing Cell Culture
In this interview, Technology Networks spoke with Dr. Laura Lyon, product manager of cell culture technologies at Sartorius, to explore the critical role of cytokines and growth factors in in vitro experiments.
Industry Insight
In Vitro Models To Advance Preclinical Drug Development
Dr. Emanuela Costigliola discusses recent advances in preclinical drug development and the significance of physiologically relevant models in predicting human responses.
Industry Insight
Scaling iPSC-Derived Cell Therapies From Innovation to Patient Care
In an interview with Technology Networks, Dr. Frederic Cedrone, vice president of corporate innovation at Catalent, discussed the challenges faced and solutions found by companies developing iPSC-derived cell therapies.
Industry Insight
Enhancing Biopharmaceutical Efficiency: Intact-Level PTM Identification and Charge Variant Analysis
In this interview, Technology Networks spoke with Dr. Jingwen Ding, senior applications scientist at SCIEX, to understand how charge variant analysis and advanced technologies can enhance biopharmaceutical workflows.
Advertisement
